TFA
ITOS

Toth Financial Advisory’s iTeos Therapeutics ITOS Stock Holding History

Toth Financial Advisory’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$1.02K – 726
2024
Q3 		$1.02K Hold
100
– – ﹤0.01% 669
2024
Q2 		$1.48K Hold
100
– – ﹤0.01% 651
2024
Q1 		$1.36K Buy
+100
New +$1.09K ﹤0.01% 657

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Toth Financial Advisory's ITOS Position: Q4 2024 in Review

Toth Financial Advisory sold out of iTeos Therapeutics (ITOS) in Q4 2024, closing a stake of 100 shares — an estimated $1.02K sold.

Toth Financial Advisory first reported a position in ITOS in Q1 2024 and held it in 3 quarters. The position peaked at $1.48K in Q2 2024. 136 funds tracked by Wall St. Rank hold ITOS as of Q4 2024.

  • Toth Financial Advisory reported no remaining iTeos Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Toth Financial Advisory sold 100 iTeos Therapeutics shares in Q4 2024, an estimated $1.02K.
  • Toth Financial Advisory first reported a position in iTeos Therapeutics in Q1 2024 and held it in 3 quarters.
  • Toth Financial Advisory's iTeos Therapeutics position peaked at $1.48K in Q2 2024.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2024.

Based on Toth Financial Advisory's 13F filing for Q4 2024, filed 21 Jan 2025.